±Þ¼º ½Å¿ì½Å¿°ÀÌ Àç¹ßÇÑ ÈÄ ºÒ¿ÏÀü °¡¿Í»ç³¢º´ÀÌ ¹ß»ýÇÑ °íµµÀÇ ¹æ±¤¿ä°ü¿ª·ù°¡ ÀÖ´Â 8°³¿ù ³²¾Æ
An 8-month-old Male Infant with High Grade Vesicoureteral Reflux who Developed Incomplete Kawasaki disease after Recurrent Pyelonephritis

´ëÇѼҾƽÅÀåÇÐȸÁö 2014³â 18±Ç 1È£ p.42 ~ p.46

Á¤¼öÁø(Jung Su-Jin) - CHAÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø ¼Ò¾Æû¼Ò³â°ú
¹Ú¼ºÀº(Park Sung-Eun) - °­µ¿¼º½Éº´¿ø
ÀÌÁØÈ£(Lee Jun-Ho) - CHAÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø ¼Ò¾Æû¼Ò³â°ú

Abstract

°¡¿Í»ç³¢º´Àº Àü½Å¼º Ç÷°ü¿°À» ÀÏÀ¸Å°´Â ÁúȯÁßÀÇ Çϳª·Î ¿©·¯ Àå±âµéÀ» ħ¹üÇÒ ¼ö ÀÖ´Ù. ½ÅÀåÁõ¼¼·Î´Â ³ó´¢, Ç÷´¢, ´Ü¹é´¢, °£Áú¼º ½Å¿°, ±Þ¼º ½ÅºÎÀüÁõ, ¿ëÇ÷¼º ¿äµ¶ ÁõÈıº, ½Å¹ÝÈç µîÀÌ ÀÖ´Ù. °¡¿Í»ç³¢º´ÀÇ ½ÅÀåħ¹ü¿¡ ´ëÇÑ º´¸®±âÀüÀº ¾ÆÁ÷ ¾Ë·ÁÁ® ÀÖÁö ¾ÊÁö¸¸, ÀÚ°¡¸é¿ªÁúȯÀ¸·Î ÀÎÇÑ°ÍÀ¸·Î »ç·ÁµÈ´Ù. °¡¿Í»ç³¢º´ÀÌ ¿ä·Î°¨¿° ÀÌ ÈÄ¿¡ ¹ßº´ÇÑ´Ù´Â ¸î¸î º¸°íµéÀÌ ÀÖ¾ú´Ù. ÇÏÁö¸¸, ÀÌ¹Ì º¸°íµÈ ³í¹®µé¿¡Æ÷ÇÔµÈ ¸¹Àº ¿ä·Î°¨¿° ȯÀÚµéÀº ½ÅÀå¹æ±¤ ÃÊÀ½ÆÄ, DMSA½ºÄµÀ̳ª ¹è´¢Áß ¿äµµ¹æ±¤Á¶¿µ¼ú µîÀ» ¸ðµÎ ¹ÞÀº °æ¿ì´Â¾ø¾ú´Ù. ÀÌ¿¡ ÀúÀÚµéÀº ±Þ¼º ½Å¿ì½Å¿°ÀÌ Àç¹ßÇÑ ÈÄ ºÒ¿ÏÀü°¡¿Í»ç³¢º´ÀÌ ¹ß»ýÇÑ °íµµÀÇ ¹æ±¤¿ä°ü¿ª·ù°¡ ÀÖ´Â 8°³¿ù³²¾Æ¸¦ º¸°íÇÏ´Â ¹ÙÀÌ´Ù. ±Þ¼º ½Å¿ì½Å¿°Àº °¡¿Í»ç³¢º´ÀÇÃʱâ Áõ¼¼ÀÏ ¼ö ÀÖ´Ù. ±×·± °æ¿ì, ȯ¾Æ°¡ °¡¿Í»ç³¢º´À¸·Î È®ÁøµÇ´õ¶óµµ ¿ä·Î°¨¿° Áø·áÁöħ¿¡ µû¶ó ¿ä·Î±âÇü¿¡ ´ëÇÑ À̹ÌÁö °Ë»ç¸¦ ½ÃÇàÇÒ ÇÊ¿ä°¡ ÀÖ´Ù°í »ý°¢ÇÑ´Ù.
Kawasaki disease (KD) is a systemic vasculitis that can affect many organ systems.
Renal manifestations include pyuria, hematuria, proteinuria, tubulointerstitialnephritis, acute renal failure, hemolytic uremic syndrome, or renal scarring. Althoughits precise pathogenesis remains unknown, it is considered an autoimmunedisease.
In the literature, it has been reported that KD may develop in conjunction withurinary tract infections. However, many of these previous studies did not useimaging methods such as renal sonograms, dimercaptosuccinic acid renal scans,and voiding urethrocystograms. We report a case of an 8-month old male infantwith high grade vesicoureteral reflux, who developed incomplete KD afterrecurrent pyelonephritis. Acute pyelonephritis can be an early manifestation ofKD. Such cases require the evaluation of urinary tract anomalies according tothe guidelines for the management of urinary tract infections.

Å°¿öµå

Kawasaki disease, Pyelonephritis, Urinary tract infection, Vesicoureteral reflux
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå